УКР
РУС
ENG
Customer Login:
Newswires
new
Terminal
Newswires
Home
Facts
Economy
Sport
Investments
Diplomacy
Regions
Projects
# Red Cross
# Restoration of Ukraine
# War
# Energy
Press Center
Products & Services
About agency
About agency
Products & Services
Press Center
Customer Login:
Terminal
Newswires
new
УКР
РУС
ENG
Trial Access
Home
Facts
Economy
Sport
Investments
Diplomacy
Regions
Projects
Special Topics:
Red Cross
Restoration of Ukraine
War
Energy
Open4business
#farmak
11:10
18.11.2025
Ukrainian pharma manufacturers lose 3-5% of revenues due to state regulation – expert
16:58
19.11.2024
Ukrainian business performs more functions than usual during the war - press conference
10:46
05.06.2023
Farmak buys marketing pharmaceutical companies in the Czech Republic, Slovakia, Ukraine
20:20
28.04.2023
Less than 5% of Farmak employees who left Ukraine because of war remain abroad
10:23
15.06.2022
Shareholders of Farmak pharmaceutical company re-elect supervisory board, its head
18:14
26.05.2022
EBRD provides EUR 20 mln loan to Farmak
14:13
05.01.2022
Farmak invests over $1.2 mln in MedTech, HealthCare projects and startups
16:14
10.09.2021
Renovation of industrial facilities provides opportunities for development of domestic pharma production facilities – expert
18:03
01.09.2021
Farmak automates recruitment procedure
18:38
05.08.2021
Farmak increases exports to Latin America
16:12
21.07.2021
Farmak pharmaceutical company to invest EUR 30 mln in building innovative R&D center in Kyiv
16:49
17.06.2021
Post-COVID rehabilitation should be started even during illness – experts
18:10
31.05.2021
Farmak executive director Kostiuk enters top 25 successful managers of Ukrainian companies
13:38
28.05.2021
Farmak makes it to rating of five most sustainable companies
17:08
28.04.2021
Farmak raises capital investments by almost 80% in 2020
18:31
27.04.2021
Farmak's brand value estimated at $94.09 mln in 2021
17:09
23.04.2021
It may take about year to launch COVID-19 vaccines production in Ukraine – Farmak's executive director
14:49
21.04.2021
FARMAK JSC reiterates support for México’s international bidding process for medical supplies.
18:56
29.03.2021
Farmak raises net profit by 7.8% in 2020
12:06
24.03.2021
Farmak notes strategic role of partnership with EBRD
17:33
15.02.2021
Farmak plans to develop R&D cluster due to Kyiv City Council decision to sell land plot to company
16:35
19.11.2019
Farmak presents results of laboratory studies of medicines in foreign clinics
14:52
10.07.2019
Farmak raises EUR 15 mln loan from EBRD
12:23
05.07.2019
Ex-Kyivstar president Chernyshov joins Farmak's supervisory board
16:25
19.03.2019
Violation of intellectual property rights by Ukrainian pharma producers results in disengagement of foreign investors – expert
1
Next →
PRESS RELEASES
ESG in Ukrainian Business: ZAMMLER Logistics Company Applies International Techniques to Calculate Its Own Carbon Footprint
‘Is light ahead?’ The 18th Kyiv Security Forum will take place on 23–24 April
Bukovel and MAVKA Aquapark are among the TOP companies in the Opendatabot rating for financial reporting transparency
PRESS CONFERENCES
Retreat from Donbas to increase threat to other Ukrainian cities - experts
Tax pressure on Ukrainians to increase severalfold if order to retreat from Donbas signed - experts
Experts say President and Rada lack authority to cede Ukrainian territories
Ukrainians have a negative attitude toward the influence of the military on electoral processes – Active Group study
Only 16% of local IDP support programs have clear, measurable indicators – KNEU Disinformation Lab head
AD
AD
